| Structure |
Chemical Name |
CAS |
MF |
 |
Tigecycline |
1337920-34-9 |
C23H28N4O7.BrH |
 |
Regofenib impurity K |
|
|
 |
Canagliflozin Monoacetyl Impurity |
|
|
 |
(3R,5S,E)-tert-butyl 7-(4-(2-fluorophenyl)-6-isopropyl-2-(N-methyl methylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate |
|
|
 |
1-(3,4-Dimethoxyphenyl)-2-(methylsulfonyl)ethan-1-amine |
1255909-25-1 |
C11H17NO4S |
 |
Cabozantinib impurity L |
|
|
 |
(S)-8-(3-aMinopiperidin-1-yl)-7-(but-2-ynyl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione |
668269-51-0 |
C25H28N8O2 |
 |
N-アセチル-1,4-ベンゾキノンイミン |
50700-49-7 |
C8H7NO2 |
 |
Trelagliptin Impurity 7 |
|
|
 |
Etoposide Impurity 3 |
|
|
 |
D-Asn4-Carbetocin (Impurity F) |
|
|
 |
Nimodipine Impurity 3 |
101072-61-1 |
C11H9NO5 |
 |
Trelagliptin Impurity 29 |
|
|
 |
Itraconazole iMpurity 4 |
|
|
 |
2-Hydroxy-5-(4-pyridyl)pyridine |
62749-34-2 |
C10H8N2O |
 |
Rocuronium Bromide Impurity 20 |
|
|
 |
Lenvatinib Impurity 42 |
|
|
 |
Cabozantinib impurity M |
|
|
 |
Ethyl 4-bromo-3-hydroxybutyrate |
32224-01-4 |
C6H11BrO3 |
 |
Bupivacaine Impurity |
852804-30-9 |
C22H37N2O |
 |
Sugammadex sodium Org244517-1 Impurity |
|
|
 |
Etoricoxib Impurity 31 |
|
|
 |
Nifedipine Impurity J |
114709-68-1 |
C16H17N3O5 |
 |
(S,S,R,R)-オリスタット |
111466-62-7 |
C29H53NO5 |
 |
L-erythro-Hexuronic acid, 3,5-dideoxy-, 1,1-dimethylethyl ester |
1501982-84-8 |
C10H18O5 |
 |
4-(モルホリン-4-イル)-1,2,5-チアジアゾール-3-オール |
30165-97-0 |
C6H9N3O2S |
 |
(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium |
2480467-84-1 |
C28H35NO7S |
 |
Voriconazole (2R,3R)-Isomer |
137234-76-5 |
C16H13ClF3N5O |
 |
Relugolix Impurity 1 |
3009131-53-4 |
|
![(4R,5S,6S)-3-[[(3S,5S)-1-[(4-Aminophenyl)methyl]-5-[[(3-carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid Sodium Salt](/CAS/20210111/GIF/866186-66-5.gif) |
(4R,5S,6S)-3-[[(3S,5S)-1-[(4-Aminophenyl)methyl]-5-[[(3-carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid Sodium Salt |
866186-66-5 |
C29H33N4NaO7S |
 |
ClarithroMycin IMpurity G |
127182-44-9 |
C39H72N2O13 |
 |
Flurbiprofen Impurity |
64858-90-8 |
C17H17FO2 |
 |
Butanoic acid, L-2-aminobutanoyl-L-2-amino-, methyl ester (9CI) |
772292-30-5 |
C9H18N2O3 |
![Acetic acid, 2-[(4-oxo-2-phenyl-4H-1-benzopyran-7-yl)oxy]-, methyl ester](/CAS/20210305/GIF/27654-54-2.gif) |
Acetic acid, 2-[(4-oxo-2-phenyl-4H-1-benzopyran-7-yl)oxy]-, methyl ester |
27654-54-2 |
C18H14O5 |
 |
Levetiracetam Impurity 24 |
|
|
 |
(E)-4-Acetoxy Tamoxifen |
76117-70-9 |
C28H31NO3 |
 |
3,4-ジメトキシサリチルアルデヒド |
19283-70-6 |
C9H10O4 |
 |
FEXOFENADINE EP IMPURITY A - HCl |
153439-43-1 |
C32H38ClNO4 |
 |
Ticagrelor Related Compound 55 |
|
|
 |
Rivaroxaban Impurity 23 |
|
|
 |
Dapoxetine impurity 61 |
|
|
 |
Mirabegron iMpurity |
1581285-26-8 |
C16H21ClN2 |
 |
ceftazidiMe iMpurity C |
|
|
 |
(R)-4-チアゾリジンカルボン酸メチル |
42258-90-2 |
C5H9NO2S |
 |
4-PYRIDIN-4-YL-BUTYRIC ACID |
102878-73-9 |
C9H11NO2 |
 |
Dexmedetomidine Impurity 19 |
|
|
![2-(3-(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile](/CAS/20211123/GIF/2402776-84-3.gif) |
2-(3-(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile |
2402776-84-3 |
C23H27N9O4S2 |
 |
1,2-bis(bromomethyl)-4,5-dimethoxybenzene |
26726-81-8 |
C10H12Br2O2 |
![8-(benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium chloride](/CAS/20180528/GIF/2143944-64-1.gif) |
8-(benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium chloride |
2143944-64-1 |
C16H21N2S+ |
 |
4-Defluoro-4-hydroxy Gefitinib |
847949-50-2 |
C22H25ClN4O4 |
 |
Dapagliflozin Impurity 10 |
960404-86-8 |
C21H25ClO7 |
 |
Aztreonam Impurity 6 |
|
|
 |
Citalopram Related Compound F |
|
|
 |
Pitavastatin 3-Oxo SodiuM |
2245811-12-3 |
C25H22FNO4 |
 |
Peramivir Impurity 60 |
|
|
 |
Sitagliptin Impurity 12 |
1803026-54-1 |
C16H12F6N4O |
 |
Loxoprofen Impurity I |
|
|
![Butanoic acid, 2-[3-[[2-benzoxazolyl[3-(4-hydroxyphenoxy)propyl]amino]methyl]phenoxy]-](/CAS/20210305/GIF/848260-34-4.gif) |
Butanoic acid, 2-[3-[[2-benzoxazolyl[3-(4-hydroxyphenoxy)propyl]amino]methyl]phenoxy]- |
848260-34-4 |
C27H28N2O6 |
 |
Prasugrel Impurity III |
1391194-50-5 |
C20H20FNO3S |
 |
Afatinib Impurity 14 |
|
|
 |
カルベジロールビスアルキルピロカテコール不純物 |
1346602-98-9 |
C40H42N4O6 |
 |
ethyl (Z)-3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate |
|
|
![6-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-(2-oxo-1,2-dihydroquinolin-7-yloxy)butyl)quinolin-2(1H)-one](/CAS/20180702/GIF/CB43038765.gif) |
6-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-(2-oxo-1,2-dihydroquinolin-7-yloxy)butyl)quinolin-2(1H)-one |
|
C38H40N4O4S |
 |
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo-, ethyl ester |
2489671-14-7 |
C17H18FNO5 |
 |
(R)-4α-チアゾリジンカルボン酸エチル |
60664-15-5 |
C6H11NO2S |
 |
Thiamine EP Impurity F HCl |
4102-72-1 |
C13H19N4OS.ClH.Cl |
 |
Escitalopram Butyryl Impurity |
1803244-58-7 |
C25H33FN2O2 |
 |
Olaparib Impurity 22 |
|
|
 |
Procaine Impurity 2 |
|
C13H20N2O2 |
 |
4-((TERT-ブチルトキシカルボニル)アミノ)シクロペント-2-エンカルボン酸(1S,4R)-メチル |
168683-02-1 |
C12H19NO4 |
 |
Riluzole 4-Bromo Impurity |
144631-82-3 |
C8H4BrF3N2OS |
 |
methyl 4-hydroxy-6-phenoxyisoquinoline-3-carboxylate |
1509958-11-5 |
C17H13NO4 |
![Fluconazole IMpurity [1, 3-Bis(1H-1, 2, 4-Triazole-1-yl)propan-2-one]](/CAS/20150408/GIF/CB42674319.gif) |
Fluconazole IMpurity [1, 3-Bis(1H-1, 2, 4-Triazole-1-yl)propan-2-one] |
1449785-88-9 |
C10H7F2N3O |
![sodium (6R,7S)-7-(2-mercaptoacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate](/) |
sodium (6R,7S)-7-(2-mercaptoacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
 |
Avatrombopag Impurity 35 |
|
|
![1-Naphthalenecarboxylic acid, 8-[[(3S)-1-azabicyclo[2.2.2]oct-3-ylamino]methyl]-5,6,7,8-tetrahydro-, (8S)-](/CAS/20210111/GIF/2407763-21-5.gif) |
1-Naphthalenecarboxylic acid, 8-[[(3S)-1-azabicyclo[2.2.2]oct-3-ylamino]methyl]-5,6,7,8-tetrahydro-, (8S)- |
2407763-21-5 |
C19H26N2O2 |
![LISINOPRIL RELATED COMPOUND A ((S)-2-{(3S,8AS)-3-(4-AMINOBUTYL)-1,4-DIOXOHEXAHYDROPYRROLO[1,2-A]PYRAZIN-2(1H)-YL}-4-PHENYLBUTANOIC ACID)](/CAS/GIF/328385-86-0.gif) |
LISINOPRIL RELATED COMPOUND A ((S)-2-{(3S,8AS)-3-(4-AMINOBUTYL)-1,4-DIOXOHEXAHYDROPYRROLO[1,2-A]PYRAZIN-2(1H)-YL}-4-PHENYLBUTANOIC ACID) |
328385-86-0 |
C21H29N3O4 |
 |
Brimonidine Impurity E |
168329-48-4 |
C9H8BrN5 |
![2-クロロ-10-[3-(メチルアミノ)プロピル]-10H-フェノチアジン](/CAS/GIF/1225-64-5.gif) |
2-クロロ-10-[3-(メチルアミノ)プロピル]-10H-フェノチアジン |
1225-64-5 |
C16H17ClN2S |
![Methyl 2-oxo-3-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)Methyl)-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate](/CAS/20130318/GIF/CB02611251.gif) |
Methyl 2-oxo-3-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)Methyl)-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate |
1403474-78-1 |
C24H18N4O5 |
![8-Chloro-1-methyl-6-phenyl-4H-Imidazo[1,5-a][1,4]benzodiazepine](/CAS/GIF/59467-86-6.gif) |
8-Chloro-1-methyl-6-phenyl-4H-Imidazo[1,5-a][1,4]benzodiazepine |
59467-86-6 |
C18H14ClN3 |
 |
フルボキサミノ酸 |
192876-02-1 |
C14H19F3N2O2 |
![4-メチルベンゼンスルホン酸3-シクロプロピル-1-(2-フルオロ-4-ヨードフェニル)-6,8-ジメチル-2,4,7-トリオキソ-1,2,3,4,7,8-ヘキサヒドロピリド[2,3-D]ピリミジン-5-イル](/CAS/GIF/871700-32-2.gif) |
4-メチルベンゼンスルホン酸3-シクロプロピル-1-(2-フルオロ-4-ヨードフェニル)-6,8-ジメチル-2,4,7-トリオキソ-1,2,3,4,7,8-ヘキサヒドロピリド[2,3-D]ピリミジン-5-イル |
871700-32-2 |
C25H21FIN3O6S |
 |
(4S,TRANS)-1,1-ジメチルエチル-6-アミノエチル-2,2-ジメチル-1,3-ジオキサン-4-アセタート |
1105067-89-7 |
C14H27NO4 |
 |
2-ヒドロキシ-5-ベンジルオキシアセトフェノン |
30992-63-3 |
C15H14O3 |
 |
N-(5-Formyl-2-hydroxyphenyl)formamide |
903563-43-9 |
C8H7NO3 |
 |
Oseltamivir Impurity 80 |
|
|
 |
Anestagnate |
|
|
![N,N'-Vis[2-(3,4-dimethoxyphenyl)ethyl]-N,N'-dimethyl-1,3-propanediamine dihydrochloride](/CAS/20180808/GIF/63434-11-7.gif) |
N,N'-Vis[2-(3,4-dimethoxyphenyl)ethyl]-N,N'-dimethyl-1,3-propanediamine dihydrochloride |
63434-11-7 |
C25H39ClN2O4 |
 |
Vonoprazan Impurity 58 |
|
|
 |
PIVALOYLOXYMETHYL 6-AMINOPENICILANATE |
25031-08-7 |
C14H22N2O5S |
 |
Milrinone IMpurity 4 |
|
|
 |
AMisulpride IMpurity D |
71676-00-1 |
C16H25N3O4S |
 |
2-Hydrazinoadenosine |
15763-11-8 |
C10H15N7O4 |
 |
Moxifloxacin Impurity 30 |
1395056-42-4 |
C21H24FN3O7 |
 |
1-(3-アミノ-5-(ベンジルオキシ)-2-ヒドロキシフェニル)エタノン |
861841-90-9 |
C15H15NO3 |
 |
Hydroxyzine Acetic Acid Dihydrochloride |
83881-56-5 |
C23H29ClN2O4 |
 |
4(1H)-Pyridinone, 2-(hydroxymethyl)-3,5-dimethyl- (9CI) |
220757-73-3 |
C8H11NO2 |
 |
(R)-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)benzenediazonium tetrafluoroborate |
1630761-21-5 |
C11H11N4O+ |
 |
Ticagrelor Impurity 44 |
|
|